- Home
- DGICB vs AMLX Comparison
DGICB vs AMLX Comparison
Compare DGICB & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICB
- AMLX
- Stock Information
- Founded
- DGICB 1986
- AMLX 2014
- Country
- DGICB United States
- AMLX United States
- Employees
- DGICB N/A
- AMLX N/A
- Industry
- DGICB Property-Casualty Insurers
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- DGICB Finance
- AMLX Health Care
- Exchange
- DGICB Nasdaq
- AMLX Nasdaq
- Market Cap
- DGICB 431.9M
- AMLX 481.9M
- IPO Year
- DGICB N/A
- AMLX 2022
- Fundamental
- Price
- DGICB $14.11
- AMLX $4.76
- Analyst Decision
- DGICB
- AMLX Buy
- Analyst Count
- DGICB 0
- AMLX 7
- Target Price
- DGICB N/A
- AMLX $6.00
- AVG Volume (30 Days)
- DGICB 392.0
- AMLX 1.7M
- Earning Date
- DGICB 10-24-2024
- AMLX 11-07-2024
- Dividend Yield
- DGICB 4.39%
- AMLX N/A
- EPS Growth
- DGICB 148.60
- AMLX N/A
- EPS
- DGICB 0.74
- AMLX N/A
- Revenue
- DGICB $979,119,004.00
- AMLX $196,485,000.00
- Revenue This Year
- DGICB N/A
- AMLX N/A
- Revenue Next Year
- DGICB $6.66
- AMLX $149.49
- P/E Ratio
- DGICB $21.13
- AMLX N/A
- Revenue Growth
- DGICB 7.44
- AMLX N/A
- 52 Week Low
- DGICB $10.75
- AMLX $1.58
- 52 Week High
- DGICB $16.00
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- DGICB 52.01
- AMLX 45.23
- Support Level
- DGICB $13.34
- AMLX $4.88
- Resistance Level
- DGICB $14.90
- AMLX $7.27
- Average True Range (ATR)
- DGICB 0.11
- AMLX 0.59
- MACD
- DGICB -0.02
- AMLX -0.18
- Stochastic Oscillator
- DGICB 49.28
- AMLX 7.03
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.